We are live on
!
Find out more
China SXT Pharmaceuticals
SXTC
SXTC
hedge funds and large institutions have $30K invested in China SXT Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
11.52% less ownership
Funds ownership: 12.87% → 1.35% (-12%)
63% less capital invested
Capital invested by funds: $79.9K → $30K (-$50K)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$34K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17.4K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$327 |